1. MBRS-29. IN-VIVO METABOLITE PROFILES FOR THE NON-INVASIVE AND RAPID IDENTIFICATION OF MOLECULAR SUBGROUP IN MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Kohe, Sarah E; Babourina-Brooks, Ben; Scerif, Fatma; Hicks, Debbie; Schwalbe, Ed C; Crosier, Stephen; Lindsey, Janet; Adiamah, Magretta; Storer, Lisa C D; Lourdusamy, Anbarasu; Gill, Simrandip K; Bennett, Christopher D; Wilson, Martin; Avula, Shivaram; Mitra, Dipayan; Dineen, Rob; Bailey, Simon; ... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MEDB-79. MYC-driven upregulation of thede novo serine and glycine pathway is a novel therapeutic target for Group 3 MYC-amplified Medulloblastoma. (3rd June 2022) Authors: Adiamah, Magretta; Lindsey, Janet C; Burté, Florence; Kohe, Sarah; Morcavallo, Alaide; Blair, Helen; Hill, Rebecca M; Singh, Mankaran; Crosier, Stephen; Zhang, Tong; Maddocks, Oliver; Peet, Andrew; Chesler, Louis; Hickson, Ian; Maxwell, Ross; Clifford, Steven C Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗